Franklin Resources Inc Praxis Precision Medicines, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.75 - $11.34 $480,921 - $3.12 Million	-274,812 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$16.76 - $22.99 $100 - $137	6 Added 0.0%	274,812 $5.41 Million
Q2 2021 Aug 13, 2021	BUY	$18.28 - $33.05 $453,344 - $819,639	24,800 Added 9.92%	274,806 $5.02 Million
Q4 2020 Feb 10, 2021	BUY	$27.25 - $55.82 $6.81 Million - $14 Million	250,006 New	250,006 $13.8 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.4B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.